Literature DB >> 30573421

Controversies in Drug Allergy: Radiographic Contrast Media.

Mario Sánchez-Borges1, Werner Aberer2, Knut Brockow3, Gulfem E Celik4, Josefina Cernadas5, Paul A Greenberger6, Marie-Soleil Masse7, Rik Schrijvers8, Axel Trautmann9.   

Abstract

The risk for developing immediate or delayed hypersensitivity reactions to radiocontrast media (RCM) interferes with the diagnosis and treatment of a number of patients requiring imaging diagnostic methods for many common diseases. A group of experts met in Orlando, Florida, in March 2018 to analyze the similarities and differences in the management of RCM reactions in different areas of the world. This paper presents a summary of the recommendations provided by this consensus group, highlighting controversial issues and unmet needs that require further research.
Copyright © 2019 American Academy of Allergy, Asthma & Immunology. All rights reserved.

Entities:  

Keywords:  Anaphylaxis; Drug allergy; Premedication; RCM; Radiographic contrast media; Skin testing

Mesh:

Substances:

Year:  2018        PMID: 30573421     DOI: 10.1016/j.jaip.2018.06.030

Source DB:  PubMed          Journal:  J Allergy Clin Immunol Pract


  13 in total

1.  Reduced iodinated contrast media dose and injection speed for CT: how much does this decrease the risk of a hypersensitivity reactions?

Authors:  Knut Brockow
Journal:  Quant Imaging Med Surg       Date:  2020-02

Review 2.  Diagnosis and Prevention of Hypersensitivity Reactions to Iodinated Contrast Media.

Authors:  Hye-Ryun Kang; Jiung Jeong; Knut Brockow
Journal:  Allergy Asthma Immunol Res       Date:  2022-07       Impact factor: 5.096

Review 3.  Radiocontrast Media Hypersensitivity Reactions in Children.

Authors:  Francesca Saretta; Silvia Caimmi; Francesca Mori; Annamaria Bianchi; Paolo Bottau; Giuseppe Crisafulli; Fabrizio Franceschini; Lucia Liotti; Claudia Paglialunga; Giampaolo Ricci; Carlo Caffarelli
Journal:  Medicina (Kaunas)       Date:  2022-04-05       Impact factor: 2.948

4.  Predicting acute adverse contrast mean reactions following cardiac catheterization: a complex undertaking.

Authors:  Marco Di Maio; Davide Capodanno
Journal:  J Thorac Dis       Date:  2019-07       Impact factor: 2.895

Review 5.  The Use of Bruton's Tyrosine Kinase Inhibitors to Treat Allergic Disorders.

Authors:  Melanie C Dispenza
Journal:  Curr Treat Options Allergy       Date:  2021-04-16

6.  COVID-19 vaccines and vaccine hesitancy: Role of the allergist/immunologist in promotion of vaccine acceptance.

Authors:  Joseph A Bellanti
Journal:  Allergy Asthma Proc       Date:  2021-08-09       Impact factor: 2.587

Review 7.  Assessment of immediate and non-immediate hypersensitivity contrast reactions by skin tests and provocation tests: A review.

Authors:  Rakesh D Bansie; A Faiz Karim; Maurits S van Maaren; Maud Aw Hermans; Paul LA van Daele; Roy Gerth van Wijk; Saskia M Rombach
Journal:  Int J Immunopathol Pharmacol       Date:  2021 Jan-Dec       Impact factor: 3.219

8.  Acute Urticaria in Inpatients Undergoing Non-emergent Coronary Angiography With Corticosteroid Prophylaxis: A Retrospective Study.

Authors:  Bangtao Chen; Fubing Yu; WenChieh Chen; Yong Wang; Fei Hao
Journal:  Front Med (Lausanne)       Date:  2021-06-10

Review 9.  Drug hypersensitivity reactions in Asia: regional issues and challenges.

Authors:  Bernard Yu-Hor Thong; Michaela Lucas; Hye-Ryun Kang; Yoon-Seok Chang; Philip Hei Li; Min Moon Tang; James Yun; Jie Shen Fok; Byung-Keun Kim; Mizuho Nagao; Iris Rengganis; Yi-Giien Tsai; Wen-Hung Chung; Masao Yamaguchi; Ticha Rerkpattanapipat; Wasu Kamchaisatian; Ting Fan Leung; Ho Joo Yoon; Luo Zhang; Amir Hamzah Abdul Latiff; Takao Fujisawa; Francis Thien; Mariana C Castells; Pascal Demoly; Jiu-Yao Wang; Ruby Pawankar
Journal:  Asia Pac Allergy       Date:  2020-01-30

10.  Pharmacological prevention of delayed hypersensitivity reactions caused by iodinated contrast media.

Authors:  Jung-Hyun Kim; Sang Il Choi; Yoon Jin Lee; Byung-Keun Kim; Heung-Woo Park; Sang-Heon Cho; Yoon-Seok Chang; Sae-Hoon Kim
Journal:  World Allergy Organ J       Date:  2021-07-01       Impact factor: 4.084

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.